The rise of deep-cold storage drugs: Challenges and solutions with Victoria De la Torre

mRNA. saRNA. DNA drugs. Only some of the groundbreaking medical developments that offer new possibilities for treating different diseases. The stability of these biological drugs, until they are injected, is mainly achieved with storage at deep-cold temperatures. This brings several significant challenges for pharmaceutical companies.

This webinar will explore the complexities of deep-cold requirements and unveil a novel glass solution – EVERIC® freeze. As the first glass vial with optimized strength for applications down to -80°C, EVERIC® freeze promises to redefine the biological drug storage landscape.

Register for the SCHOTT ID and get access to SCHOTT Pharma exclusive content:

SCHOTT ID is your central key to valuable information and features related to our products and applications. Whether you are an interested party, customer, or partner, you can benefit from simplified access to extended content, practical tools, and digital offerings alongside our range of products.